Insights

Innovative Monitoring Technology Biobeat's FDA-cleared cuffless blood pressure monitoring devices and advanced health-AI platform offer a unique value proposition for healthcare providers seeking non-invasive, continuous patient monitoring solutions, opening opportunities for partnerships with hospitals, clinics, and home health services.

Growing Market Presence With recent recognition as a Rising Star Finalist at the HLTH digital Health Awards and inclusion in digital health competitions, Biobeat is positioned as a reputable innovator in digital health, making it attractive for health systems looking to adopt cutting-edge remote monitoring technologies.

Enhanced Patient Engagement The launch of the Patient Diary app enhances patient data collection and engagement, providing a pathway for integrating patient-reported outcomes and bi-directional communication, which could be leveraged to upsell or expand digital health solutions.

Data-Driven Care Capabilities Biobeat's extensive vital-sign database and AI-powered early warning alerts enable proactive patient management, making it appealing for healthcare providers aiming to improve clinical outcomes through data-driven insights in chronic disease management and hospital-at-home models.

Market & Funding Positioning With a revenue range of 10 to 25 million dollars and recent $8 million funding, Biobeat is scalable and looking to expand its customer base, offering opportunities for sales teams to target health systems, elder care, and telehealth companies seeking innovative remote monitoring solutions.

Biobeat Tech Stack

Biobeat uses 8 technology products and services including Cloudflare CDN, WordPress, RSS, and more. Explore Biobeat's tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • WordPress
    Content Management System
  • RSS
    Content Management System
  • Google Fonts API
    Font Scripts
  • Microsoft
    Miscellaneous
  • Elementor
    Page Builders
  • Google Tag Manager
    Tag Management
  • Bootstrap
    UI Frameworks

Media & News

Biobeat's Email Address Formats

Biobeat uses at least 1 format(s):
Biobeat Email FormatsExamplePercentage
First@bio-beat.comJohn@bio-beat.com
47%
Last@bio-beat.comDoe@bio-beat.com
3%
First@bio-beat.comJohn@bio-beat.com
47%
Last@bio-beat.comDoe@bio-beat.com
3%

Frequently Asked Questions

Where is Biobeat's headquarters located?

Minus sign iconPlus sign icon
Biobeat's main headquarters is located at Tel Aviv, IL. The company has employees across 3 continents, including AsiaNorth AmericaEurope.

What is Biobeat's official website and social media links?

Minus sign iconPlus sign icon
Biobeat's official website is bio-beat.com and has social profiles on LinkedInCrunchbase.

What is Biobeat's NAICS code?

Minus sign iconPlus sign icon
Biobeat's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Biobeat have currently?

Minus sign iconPlus sign icon
As of September 2025, Biobeat has approximately 43 employees across 3 continents, including AsiaNorth AmericaEurope. Key team members include Chief Financial Officer: R. Z.Co-Founder And Ceo: A. B.Chairman Of The Board: R. W. C.. Explore Biobeat's employee directory with LeadIQ.

What industry does Biobeat belong to?

Minus sign iconPlus sign icon
Biobeat operates in the Medical Equipment Manufacturing industry.

What technology does Biobeat use?

Minus sign iconPlus sign icon
Biobeat's tech stack includes Cloudflare CDNWordPressRSSGoogle Fonts APIMicrosoftElementorGoogle Tag ManagerBootstrap.

What is Biobeat's email format?

Minus sign iconPlus sign icon
Biobeat's email format typically follows the pattern of First@bio-beat.com. Find more Biobeat email formats with LeadIQ.

How much funding has Biobeat raised to date?

Minus sign iconPlus sign icon
As of September 2025, Biobeat has raised $8M in funding. The last funding round occurred on Mar 01, 2020 for $8M.

When was Biobeat founded?

Minus sign iconPlus sign icon
Biobeat was founded in 2016.
Biobeat

Biobeat

Medical Equipment ManufacturingTel Aviv, Israel11-50 Employees

Biobeat is a med-tech company with unique health-AI abilities in the patient monitoring space. The company’s remote patient monitoring (RPM) health-AI platform includes a disposable short-term chest-monitor and a long-term wrist-monitor, both of which utilize a photoplethysmography-based (PPG) sensor to continuously provide accurate patient readings of 13 health parameters, including cuffless blood pressure, pulse rate, respiratory rate, blood oxygen saturation, temperature, stroke volume, cardiac output, one lead ECG (only chest-monitor) and more. Leveraging its automatic, continuous and noninvasive RPM AI platform, Biobeat has generated the biggest vital-sign database in the world, which it utilizes to identify early deterioration of patients via its proprietary big-data and health-AI tools. 
 
Aggregated patient health data is viewed by medical staff via Biobeat’s secure HIPPA and GDPR compliant cloud-based patient management platform, which utilizes an automated real-time early warning score (EWS) system that incorporates advanced AI-based algorithms to provide alerts on patient health status and potential deterioration. These capabilities allow Biobeat to support medical teams with tailored patient care such as adjustment of therapeutics and early prevention of specific disease exacerbations. Biobeat’s wearable devices are the first devices to be FDA-Cleared for cuffless non-invasive blood pressure monitoring and are also CE Mark certified.

Section iconCompany Overview

Headquarters
Tel Aviv, IL
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $8M

    Biobeat has raised a total of $8M of funding over 2 rounds. Their latest funding round was raised on Mar 01, 2020 in the amount of $8M.

  • $10M$25M

    Biobeat's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $8M

    Biobeat has raised a total of $8M of funding over 2 rounds. Their latest funding round was raised on Mar 01, 2020 in the amount of $8M.

  • $10M$25M

    Biobeat's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.